For condition: Hidradenitis Suppurativa
Hidradenitis Suppurativa Clinical Research Trial (24 Weeks)
Study Summary
Who Can Participate?
Adults 18 to 75 years of age with hidradenitis suppurativa (HS), may be eligible.
Inclusion Criteria:
- Diagnosis of moderate to severe HS for at least 6 months
- have HS lesions affecting at least 2 different body areas
- have at least 5 lumps under the skin (abscesses and/or inflammatory nodules)
- have had an inadequate response to at least 4 weeks of treatment with oral antibiotics for the treatment of HS
Participant Info:
- No cost to participate or receive study medication
- Regular visits with study doctors who are familiar with hidradenitis suppurativa
- Will receive investigational oral medication (active study drug) or placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- Participation will last about 24 weeks and involve about 10 visits to the study research site
For more information about this trial, please visit ClinicalTrials.gov
